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 Abstract 
The objective of this review article is to study how technology is transferred in pharmaceutical industry. The 
article attempts to discuss about the technology transfer process, importance of technology transfer, reasons for using 
technology transfer, policy approaches of technology transfer, effective factors in technology transfer, Facets of technology 
transfer, goals of technology transfer, steps involved in technology transfer, barriers of technology transfer and the issues 
involved in the technology transfer in the pharmaceutical industry and understand the aspects related with technology 
transfer.  
Keywords: Technology transfer, Steps involved, Barriers, policy approaches. 
1. Introduction  
A proper technology transfer (TT) is both essential 
and important to drug discovery and development for new 
medicinal products. It is also required to upgrade drug 
quality planned during research development and to final 
product during manufacturing as well as to guarantee that 
stable quality is transferred.  
According to WHO, Transfer of technology is 
defined as “a logical procedure that controls the transfer of 
any process together with its documentation and 
professional expertise between development and 
manufacture or between manufacture sites”. It is a 
systematic procedure that is followed in order to pass the 
documented knowledge and experience gained during 
development and or commercialization to an appropriate, 
responsible and authorized party. Technology transfer 
embodies both the transfer of documentation and the 
demonstrated ability of the receiving unit (RU) to 
effectively perform the critical elements of the transferred 
technology, to the satisfaction of all parties and any 
applicable regulatory bodies. 
Technology transfer (TT) is defined as “the 
transfer of the manufacturing process for a new 
pharmaceutical Drug Substance (DS) and Drug Product 
(DP), respectively, from the transferring site (in this case 
R&D) to the receiving site or designated commercial 
manufacturing site.” This includes all   the associated 
knowledge, information and skills to be able to manufacture 
the DS and DP at the receiving site. 
The development and transfer of knowledge and 
technology has been and will continue to be critical to 
success in pharmaceutical industry. The transfer of 
technology is considered as both fundamental and 
significant to the drug discovery and development process 
for any new medicinal entity. This process is important for 
to elucidate necessary information for technology transfer 
from R & D (Research &Development) to PDL (product 
development laboratory). This review gives a brief 
description about the importance, objective, Factors, steps 
in technology transfer, various cases and barriers by which 
technology transfer takes place. 
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Why technology transfer is required in Pharmaceutical 
Industry [2] 
In the pharmaceutical industry technology transfer 
refers to the processes that are needed for successful 
progress from drug discovery to product development, to 
clinical trials to full-scale commercialization or it is the 
process bywhich a developer of technology makes its 
technology available to commercial partner that will exploit 
technology. In pharmaceutical industry preparation of 
dosage form needs scale up at several stages, such as small 
scale laboratory development from 0.5-2kgbatch can be 
scaled up to 5-10 kg and then to20-100 kg on a pilot scale. 
Production scale can typically range from 200 kg to greater 
than 1000kg. Technology transfer involves manufacturing 
drug product with increasing batch sizes on larger 
equipment or using continuous processing on pilot scale 
equipment. Generally scale up involves the transfer of 
technology and the transfer of knowledge that has been 
accumulated during the small scale development of product 
and processes. It is important to realize that good 
communication is critical for formulation and process 
transfer to be successful. It is essential for a researcher or 
developer of technology to make available this technology 
to another person’s to exploit for the progress of 
development of technology and for exploitation of a 
technology in different fields of applications and to make is 
use with another organization that may have better 
manufacturing capability, marketing capability and 
commercial capability. In the pharmaceutical industry, 
technology transfer by collaborating with other departments 
and other organizations to commercialize a pharmaceutical 
product is a common process. 
 
Figure 1: Flow chart of technology transfer in 
pharmaceutical industry [3] 
1.1 Importance of Technology Transfer in 
Pharmaceutical Industry [4, 15] 
 To elucidate necessary information to transfer technology 
from R&D to actual manufacturing by sorting out various 
information obtained during R&D; 
 To elucidate necessary information to transfer technology 
of existing products between various manufacturing 
places; 
 To exemplify specific procedures and points of concern 
for the two types of technology transfer in the above to 
contribute to smooth technology transfer. This is applies 
to the technology transfer through R&D and production 
of drug substances or drug products and the technology 
transfer related to post-marketing changes in 
manufacturing places. 
1.2 Reasons for technology transfer
 
[5, 15] 
1) Lack of manufacturing capacity: The developer of 
technology may only have manufacturing equipment 
which is suitable for small scale operation, and must 
collaborate with another organization to do large scale 
manufacturing. 
2) Lack of resources to launch product commercially: The 
original inventor of technology may only have the 
resources to conduct early-stage research such as animal 
studies and toxicology study, but doesn’t have the 
resources to take technology through its clinical and 
regulatory phases. 
3) Lack of marketing and distribution capability: The 
developer of technology may have fully developed the 
technology and even have obtained regulatory approvals 
and product registrations, but it may not have the 
marketing and distribution channels. 
4) Exploitation in a different field of application: Each 
partner may have only half of the solution i.e. the 
developer of the technology might be capable of 
exploiting the technology itself in the field of diagnostic 
applications and may grant exploitation right to 
commercial partner for the exploitation of therapeutics 
application. 
1.3 Technology transfer policy
 
[6] 
A pharmaceutical technology transfer can be 
defined as the transfer of scientific information, a capability 
or a technological basis associated with a drug or a 
pharmaceutical procedure from a donor side (knowledge 
centre) to a receptor side (drug manufacturing 
plant)implying a positive experience learned and realized 
by both sides and complying all the regulatory requirements 
in terms of Efficacy, Quality and Safety. Thus the concept 
of outsourcing and externalization comes into play as an 
opportunity entailing the delegation of activities out of the 
company as well as cessation of human resources and 
materials. 
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This concept or necessity is supposed to respond to 
a series of weak points concerning drug development 
strategies and to be either reinforced locally or outsourced 
like these; 
 Development management structure proves insufficient. 
No management educational plans in executive teams 
 Lack of equipments and infrastructure. Poor confidence 
in R & D know-how 
 Lack of introduction of Good Laboratory Practices, GLP, 
& Good Manufacturing Practices, GMP, guidelines and 
other quality systems. Realization of uncontrolled trials 
and lack of pilot trials 
 Dispersion of the research effort. Lack of focusing 
objectives and establishing merge ring and joint venture 
strategies 
 Updating and universalization of the resources available 
for all researchers. Lack of motivation and flexibility of 
researchers 
 Lack of communication with the regulatory authorities. 
Exceptional search of local and regional 
opportunities. On the other hand, the degree of outsourcing 
of development activities depends on the company’s 
strategy. 
The transfer of technology from a development 
unit (donor side) and its subsidiary companies, licensed 
ones, subcontracted ones or simply clients (receptor side) 
aims at the supply of information and methods enabling the 
receptor side to start the production of a new product, bulk 
ware or finished drug. 
Formalizing the technology transfer policy can be 
expected: 
 The objectives of the company and business are kept 
 A positive impact on the quality of the product in 
question is produced 
 The introduction of new products in the market is 
facilitated 
 The compliance with the regulatory requirements is 
assured 
 The costs are reduced 
By other hand, the drug production facilities are 
concerned by technology transfer as they are increasing 
their production capacities working for other companies. 
This implies an excellent opportunity for 
companies with either low used installations or equipments 
with a degree of exploitation of not more than 50 % of their 
maximum capacity or specialized companies with own 
procedures and technologies covering market gaps. 
1.4 Effective factors in technology transfer
 
[7] 
“Technology transfer can be considered successful 
if a Receiving Unit can routinely reproduce the transferred 
product, process or method against a predefined set of 
specifications as agreed with a Sending Unit or 
Development Unit”  
Main factors that affect the process of technology transfer 
in pharmaceutical industry are as follows: 
1) Investment in Research and Development. 
2) Establishing relationship between production and 
research. 
3) Information development in the field of technology 
transfer methods. 
4) Organizational, Equipmental and Informational 
infrastructures. 
5) Employment of International specialist in the field of 
technology and creation of appropriate relationship 
between recipient and sender technology. 
6) Awareness of fundamental and important factors required 
for technology transfer. 
7) Consideration of existing and old technologies. 
8) Degree of development and improvement of technology 
on the basis of internal resources. 
 
2. Facets of technology transfer
 
[8] 
a. Govt. labs to private sectors 
This type of Technology Transfer is advantageous 
as the Govt. labs can get good financial support and funds 
from the govt. for their research work and the technology 
developed by them reaches the private sector. 
b. Between Private sectors of same country 
This type of Technology Transfer generally occurs 
due to lack of appropriate financial resources or inadequate 
knowledge of regulatory requirements, thus the private 
sector that develops the technology is paid by other sector 
that absorbs the technology. 
c. From Academics to private sectors 
Academic sectors that are actively involved in 
research develop the technology and make it available to 
private firms. By collaboration of private firms with the 
institutions, money can be saved. 
d. Between Academy, Private and Govt. sectors 
In this type of Technology Transfer govt. provides 
necessary funds to the academic institutions in developing 
technology that can be transferred to the industry.
 
 
3. Goals of technology transfer
 
[9] 
According to ICH Q10 guidelines 
The goal of technology transfer activities is to 
transfer product and process knowledge between 
development and manufacturing, and within or between 
manufacturing sites to achieve product realization. This 
knowledge forms the basis for the manufacturing process, 
control strategy, process validation approach and on-going 
continual improvement. 
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 Is a valuable step in the developmental life cycle leading 
to successful commercial manufacturing? 
 To take all the gathered knowledge and use it as the basis 
for the manufacturing control strategy, the approach to 
process qualification and on-going continuous 
improvement. 
 The transition of the product/process/analytical method 
knowledge between development and manufacturing 
sites. 
 To ensure variability of process and parameters are 
controlled and sufficient in the face of the rigors of a 
commercial production environment. To verify 
parameters established during development are still 
within the determined design space and adjusted at scale-
up.  
 
4. Steps in technology transfer [10-12, 15]
 
 Technology Transfer is not a single way process. 
Whether a tablet, a Transdermal patch, a topical ointment, 
or an injectable, the transformation of a pharmaceutical 
prototype into a successful product requires the cooperation 
of many individuals. 
 The classic view of a flow from basic to applied 
technology is a great oversimplification-sometimes, e.g. 
problems or insights arising at the production level give rise 
to new ideas that contribute to fundamental basic advance. 
At least in some sectors, close links between the basic 
researchers and manufacturing experts, and even marketing 
personnel contribute to competitiveness and advancement. 
 During development of a formulation, it is 
important to understand procedure of operations used, 
critical and non-critical parameters of each operation, 
production environment, equipment and excipient 
availability, which should be taken into account during the 
early phases of development of formulation, so that 
successful scale up can be carried out. Appropriate care 
during technology transfer is important to enhance drug 
quality as developed by R & D in final formulation as well 
as to assure quality for predetermined period of time. The 
various steps involved in technology transfer are given 
below: 
A. Development of technology by R & D [Research Phase] 
B. Technology transfer from R&D to production 
[Development Phase] 
C. Optimization and Production [Production Phase] 
A) Research Phase (Development of technology by R & 
D) 
a. Design of procedure and selection of excipients by 
R&D 
 Selection of materials and design of procedures is 
developed by R&D on the basis of innovator product 
characteristics. For this different test and compatibility 
studies are done. 
b. Identification of specification and quality by R&D 
   Generally it should be considered by R & D the 
quality of product should meet the specifications of an 
innovator product. For this different stability studies are 
carried out for innovator product and for product which is 
to be manufactured. 
B) Development Phase (Technology transfer from R&D 
to production) 
   R&D provides technology transfer dossier (TTD) 
document to product development laboratory which 
contains all information of formulation and drug product as 
given below. 
Technology Transfer Dossier (TTD): TTD contained all 
the information of drug product as given below: 
 Master formula card (MFC) 
 Master Packaging Card (MPC) 
 Master formula 
 Standard Test Procedures 
 Specifications 
 Development report 
 Packaging development report 
Master formula card (MFC): MFC included Product 
name along with its Strength, Generic name, MFC number, 
Page number, Effective date, shelf life, market, packaging 
details, storage conditions, precautions for personnel safety 
as well as for the product safety. Ingredients details with 
pharmacopoeial status along with the specifications 
numbers, brand names / grades along with approved 
vendors label claim and a brief manufacturing detail 
Masters packaging card: It gives information about 
packaging type, material use for packaging, stability profile 
of packaging and shelf life of packaging. 
Master formula: It describes formulation order and 
manufacturing instruction. Formulation order and 
manufacturing instruction gives idea of process order, 
environment condition required and manufacturing 
instruction for dosage form development. 
Specification and standard test procedure (STPs): It 
helps to know active ingredients and excipients profiles, in 
process parameter and specification, product release 
specification and finished product detail. 
Research for factory production: To manufacture drugs 
with qualities as designed, it is required to establish 
appropriate quality control method and manufacturing 
method, after detecting variability factors to secure stable 
quality in the scale up validation that is performed to realize 
factory production of drug designed on the basis of result 
from small-scale experiments. 
Consistency between quality and specification: When 
product specification is established on the basis of the 
quality of product determined in the above, it is required to 
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verify that the specification adequately specifies the product 
quality. In short, the consistency between quality and 
specification is to ensure in the products specification that 
the quality predetermined in the quality design is assured as 
the manufacture quality and the product satisfies the quality 
of design. 
Assurance of consistency through development and 
manufacturing: To make developed product have 
indications as predetermined in clinical phases, quality of 
design should be reproducible as the quality of product 
(assurance of consistency). For this purpose transferring 
party in charge of development should fully understand 
what kind of technical information is required by the 
transferred party in charge of manufacturing and should 
establish an appropriate evaluation method to determine 
whether a drug to be manufactured meets the quality of 
design.  
C) Production Phase (Optimization and Production)  
a. Val idation studies 
   Production is implemented after various validation 
studies verify that, it is able to consistently manufacture 
product based on transferred manufacturing formula with a 
higher degree of stability. Research and development 
department transferring technology should take 
responsibility for validation such as performance 
qualification, cleaning validation and process validation 
unique to subject drugs. 
b. Scale-up for production 
Scale up involves the transfer of technology during 
the small scale development of the product and processes. It 
is essential to consider the production environment and 
system during development of process. Different operations 
e.g. dispensing, sifting, blending, compaction/dry 
granulation/wet granulation, compression, coating are used 
in the formulation of solid dosage form. From blending to 
film coating, each process is easy for pharmaceutical 
professionals to be absorbed in the particular part of the 
manufacturing process for which they are directly 
responsible. Operators concentrate on keeping their 
segment of the production process running smoothly. But 
the whole manufacturing line can be improved, even before 
production begins, if technology transfer is implemented 
thoughtfully. Effective technology transfer helps to provide 
process efficiency and control and maintain product quality. 
c. Considerations of different parameters for scale-up:  
Before starting scale-up, we also considered 
different parameters that should be optimum for successful 
technology transfer. These were: Flexibility, Cost, 
Dependability, Innovation and Product Quality. It was 
important to realize that good communication was critical 
for formulation and process transfer to be successful.  
 
d. Selection of method:  
The method for batch fabrication was selected on 
the basis of data given from R&D. Granulation, blending; 
compression and coating were critical parameters for 
technology transfer. 
D) Technology Transfer Documentation [13, 15] 
Generally interpreted as document indicating 
contents of technology transfer for transferring and 
transferred parties. Each step from R&D to production 
should be documented, task assignments and 
responsibilities should be clarified and acceptance criteria 
for completion of technology transfer concerning individual 
technology to be transferred. It is duty of Quality Assurance 
department to check and approve the documentation for all 
processes of technology transfer. 
(a) Development Report 
The R&D report is a file of technical development, 
and R&D department is in-charge of its documentation. 
This report is an important file to indicate rationale for the 
quality design of drug substances and its specifications and 
test methods. The development report is not prerequisite for 
the application for approval; it can be used at the pre-
approval an inspection as valid document for quality design 
of new drug. The development report contains –  
(1) Data of pharmaceutical development of new drug 
substances and drug products at stages from early 
development phase to final application of approval.  
(2) Information of raw materials and components.  
(3) Design of manufacturing methods. 
(4)Change in histories of important processes and control 
parameters. 
(5) Specifications and test methods of drug substances.  
(6) Validity of specification range of importanttests such as 
contents impurities and dissolution.  
(7) Verifications of results. 
(b) Technology Transfer Plan  
The technology transfer plan is to describe 
itemsand contents oftechnology to be transferred and 
detailed procedures of individual transfer and transfer 
schedule, establishjudgment criteria for the completion of 
the transfer. The transferring party should prepare the plan 
beforethe implementation of the transfer and reach an 
agreement on its contents with the transferred party. 
(c) Report  
Completion of technology transfer is to be made 
once data are takenaccordingly to thetechnology plan and 
are evaluated to confirm that the predeterminedjudgment 
criteria are met. Bothtransferring and transferred parties 
should document thetechnology transfer report. 
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E) Exhibit 
After taking scale up batch of the product, 
manufacturing of exhibit batches take place. In case of 
exhibit, batch sizes are increased along with equipment and 
their process is involved. They are done for filing purposes 
in different regulatory agencies. 
 
5. Barriers of Technology Transfer [7] 
 Lack of market share: Local producers face significant 
challenges in meeting international Quality standards and 
capturing a critical market share. Greater market share 
would increase profitability. 
 Cost of prequalification: There is benefit in meeting 
international standards since it opens up the opportunity 
for trading across the entire world. 
 Labour issues: The pharmaceutical sector demands 
relatively skilled labour. High labour turns over and 
absenteeism owing to unattractive conditions of service is 
negative contributor. 
 Unsuccessful or incomplete Process Validation. 
 High rates of batch rejections, excessive labour 
requirements, increased cost of product etc. 
 Incomplete Documentation. 
 Product does not show specifications as intended. 
 Delayed regulatory approval and/or product launch 
 
6. Few cases of technology transfer [14] 
The process of Technology Transfer is actively 
being pursued in India through Government laboratories, 
Academics Institutions and Commercial entities. 
1. The Bhabha Atomic Research Centre (BARC), has 
developed and transferred around 90 technologies in the 
areas such as environment and health; electronics; electrical 
and mechanical; chemical and metallurgy; radioisotope and 
applications. 
2. The National Chemical Laboratory (NCL) Pune, has 
several linkages with universities and pharmaceutical 
industries to ensure successful scale up and implementation 
of technology.  
3. Department of Biotech (DBT) has successfully 
transferred some techniques of forest trees through tissue 
culture. 
4. Eli Lily has entered in technology transfer agreement 
with Shasun Chemicals and Drugs for the manufacturing of 
anti T.B drug CYCLOSERINE produced by shasun to meet 
Eli Lily global demand. 
 
7. Organization of technology transfer
 
[9] 
As the team concept is always the best approach to 
achieve a successful technology transfer projects. The core 
technology transfer team must be commissions immediately 
following the decisions of the executive management to 
pursue the drug candidate to commercialization. A typical 
technology transfer core team will likely be comprised of 
individual’s representives of the different segments of the 
business. 
1) The Project Manager- The overall coordination, 
responsibility and communication progress to the 
management. His or her role may be enhanced as 
necessary by the additional staff and responsibility and 
authority delegated as appropriate.  
2) Regulatory Affairs- For the coordination of the 
appropriate regulatory filings, advice on the timing of 
approval, filing documentation contents and response to 
the regulatory inquiries.  
3) Engineering- For coordination of associated capital 
projects and direct and equipment acquisition, control the 
construction, installation and qualification.  
4) The Material management- Those units responsible for 
strategic planning, pure chasing, supply chain activities 
and resource allocation are included. These members will 
analyse and recommend the most favourable 
manufacturing strategy in consideration of partnership in 
business, internal capability, and advantages of tax for the 
corporation. 
5) The Manufacturing operations- Receiving location of 
production activities and to represent the originating site. 
These representatives should have the sufficient authority 
to commit the necessary personal and plant resource to 
achieve the project within the defined time and cost 
limitations.  
6) Research and Development [R&D]- To support the 
technical issues and resolve problems. This group 
provides the expertise process and would expect to direct 
and train the production trials at the receiving site. 
 
7. Conclusion 
Effective technology transfer is critical to success 
in pharmaceutical industry. In pharmaceutical industry 
technology transfer can be defined as the transfer of 
scientific information, a capability or a technological basis 
associated with a drug or a pharmaceutical procedure from 
a donor side (knowledge center) to a receptor side (drug 
manufacturing plant) implying a positive experience 
learned and realized by both sides and complying all the 
regulatory requirements in terms of Efficacy, Quality and 
Safety. A healthy communication between different 
countries and different organizations are the key to the 
success of Technology transfer and development. So, the 
knowledge and information should be transferred equally 
and continuously from transferring party to the transferred 
party, this will help in the product manufacturing process 
and thus the development of both the parties. 
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